Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis.

Dominik Bettinger; David J Pinato; Michael Schultheiss; Rohini Sharma; Lorenza Rimassa; Tiziana Pressiani; Michela E Burlone; Mario Pirisi; Masatoshi Kudo; Joong Won Park; Nico Buettner; Christoph Neumann-Haefelin; Tobias Boettler; Nasrin Abbasi-Senger; Horst Alheit; Wolfgang Baus; Oliver Blanck; Sabine Gerum; Mathias Guckenberger; Daniel Habermehl; Christian Ostheimer; Oliver Riesterer; Jörg Tamihardja; Anca-Ligia Grosu; Robert Thimme; Thomas Baptist Brunner; Eleni Gkika

doi:10.1159/000490260

Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis.

Dominik Bettinger, David J Pinato, Michael Schultheiss, Rohini Sharma, Lorenza Rimassa, Tiziana Pressiani, Michela E Burlone, Mario Pirisi, Masatoshi Kudo, Joong Won Park, Nico Buettner, Christoph Neumann-Haefelin, Tobias Boettler, Nasrin Abbasi-Senger, Horst Alheit, Wolfgang Baus, Oliver Blanck, Sabine Gerum (Co-author), Mathias Guckenberger, Daniel HabermehlChristian Ostheimer, Oliver Riesterer, Jörg Tamihardja, Anca-Ligia Grosu, Robert Thimme, Thomas Baptist Brunner, Eleni Gkika

Research output: Contribution to journal › Original Article (Journal) › peer-review

25 Citations (Web of Science)

Original language	English
Pages (from-to)	281-294
Journal	LIVER CANCER
Volume	8
Issue number	4
DOIs	https://doi.org/10.1159/000490260
Publication status	Published - 2019

Keywords

CLINICAL-PRACTICE GUIDELINES
QUALITY-OF-LIFE
TRANSARTERIAL CHEMOEMBOLIZATION
LIVER-TUMORS
PHASE-I
RADIOTHERAPY
ABSCOPAL
OUTCOMES
BRIDGE
EFFICACY

Access to Document

10.1159/000490260

Cite this

Bettinger, D., Pinato, D. J., Schultheiss, M., Sharma, R., Rimassa, L., Pressiani, T., Burlone, M. E., Pirisi, M., Kudo, M., Park, J. W., Buettner, N., Neumann-Haefelin, C., Boettler, T., Abbasi-Senger, N., Alheit, H., Baus, W., Blanck, O., Gerum, S., Guckenberger, M., ... Gkika, E. (2019). Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis. LIVER CANCER, 8(4), 281-294. https://doi.org/10.1159/000490260

@article{0312e7e93cc94accbfb224c752c4db17,

title = "Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis.",

keywords = "CLINICAL-PRACTICE GUIDELINES, QUALITY-OF-LIFE, TRANSARTERIAL CHEMOEMBOLIZATION, LIVER-TUMORS, PHASE-I, RADIOTHERAPY, ABSCOPAL, OUTCOMES, BRIDGE, EFFICACY",

author = "Dominik Bettinger and Pinato, {David J} and Michael Schultheiss and Rohini Sharma and Lorenza Rimassa and Tiziana Pressiani and Burlone, {Michela E} and Mario Pirisi and Masatoshi Kudo and Park, {Joong Won} and Nico Buettner and Christoph Neumann-Haefelin and Tobias Boettler and Nasrin Abbasi-Senger and Horst Alheit and Wolfgang Baus and Oliver Blanck and Sabine Gerum and Mathias Guckenberger and Daniel Habermehl and Christian Ostheimer and Oliver Riesterer and J{\"o}rg Tamihardja and Anca-Ligia Grosu and Robert Thimme and Brunner, {Thomas Baptist} and Eleni Gkika",

year = "2019",

doi = "10.1159/000490260",

language = "English",

volume = "8",

pages = "281--294",

journal = "LIVER CANCER",

issn = "2235-1795",

number = "4",

}

Bettinger, D, Pinato, DJ, Schultheiss, M, Sharma, R, Rimassa, L, Pressiani, T, Burlone, ME, Pirisi, M, Kudo, M, Park, JW, Buettner, N, Neumann-Haefelin, C, Boettler, T, Abbasi-Senger, N, Alheit, H, Baus, W, Blanck, O, Gerum, S, Guckenberger, M, Habermehl, D, Ostheimer, C, Riesterer, O, Tamihardja, J, Grosu, A-L, Thimme, R, Brunner, TB & Gkika, E 2019, 'Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis.', LIVER CANCER, vol. 8, no. 4, pp. 281-294. https://doi.org/10.1159/000490260

TY - JOUR

T1 - Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis.

AU - Bettinger, Dominik

AU - Pinato, David J

AU - Schultheiss, Michael

AU - Sharma, Rohini

AU - Rimassa, Lorenza

AU - Pressiani, Tiziana

AU - Burlone, Michela E

AU - Pirisi, Mario

AU - Kudo, Masatoshi

AU - Park, Joong Won

AU - Buettner, Nico

AU - Neumann-Haefelin, Christoph

AU - Boettler, Tobias

AU - Abbasi-Senger, Nasrin

AU - Alheit, Horst

AU - Baus, Wolfgang

AU - Blanck, Oliver

AU - Gerum, Sabine

AU - Guckenberger, Mathias

AU - Habermehl, Daniel

AU - Ostheimer, Christian

AU - Riesterer, Oliver

AU - Tamihardja, Jörg

AU - Grosu, Anca-Ligia

AU - Thimme, Robert

AU - Brunner, Thomas Baptist

AU - Gkika, Eleni

PY - 2019

Y1 - 2019

KW - CLINICAL-PRACTICE GUIDELINES

KW - QUALITY-OF-LIFE

KW - TRANSARTERIAL CHEMOEMBOLIZATION

KW - LIVER-TUMORS

KW - PHASE-I

KW - RADIOTHERAPY

KW - ABSCOPAL

KW - OUTCOMES

KW - BRIDGE

KW - EFFICACY

U2 - 10.1159/000490260

DO - 10.1159/000490260

M3 - Original Article (Journal)

C2 - 31602371

SN - 2235-1795

VL - 8

SP - 281

EP - 294

JO - LIVER CANCER

JF - LIVER CANCER

IS - 4

ER -